These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 25884418)

  • 1. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
    Tanaka M; Ichikawa-Tomikawa N; Shishito N; Nishiura K; Miura T; Hozumi A; Chiba H; Yoshida S; Ohtake T; Sugino T
    BMC Cancer; 2015 Feb; 15():53. PubMed ID: 25884418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A14 interacts with S100A16 and regulates its expression in human cancer cells.
    Sapkota D; Costea DE; Ibrahim SO; Johannessen AC; Bruland O
    PLoS One; 2013; 8(9):e76058. PubMed ID: 24086685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A14, a member of the EF-hand calcium-binding proteins, is overexpressed in breast cancer and acts as a modulator of HER2 signaling.
    Xu C; Chen H; Wang X; Gao J; Che Y; Li Y; Ding F; Luo A; Zhang S; Liu Z
    J Biol Chem; 2014 Jan; 289(2):827-37. PubMed ID: 24285542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma.
    Sapkota D; Bruland O; Parajuli H; Osman TA; Teh MT; Johannessen AC; Costea DE
    BMC Cancer; 2015 Sep; 15():631. PubMed ID: 26353754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma.
    Ding F; Wang D; Li XK; Yang L; Liu HY; Cui W; Liu ZH; Che YQ
    Thorac Cancer; 2018 Jul; 9(7):827-835. PubMed ID: 29733545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.
    Zhu W; Xue Y; Liang C; Zhang R; Zhang Z; Li H; Su D; Liang X; Zhang Y; Huang Q; Liu M; Li L; Li D; Zhao AZ; Liu Y
    Tumour Biol; 2016 Sep; 37(9):12241-12250. PubMed ID: 27240591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological Significance of S100A14 Expression in Lung Adenocarcinoma.
    Katono K; Sato Y; Kobayashi M; Saito K; Nagashio R; Ryuge S; Igawa S; Nakashima H; Shiomi K; Satoh Y; Ichinoe M; Murakumo Y; Saegusa M; Masuda N
    Oncol Res Treat; 2017; 40(10):594-602. PubMed ID: 28950283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A14 is a novel independent prognostic biomarker in the triple-negative breast cancer subtype.
    Ehmsen S; Hansen LT; Bak M; Brasch-Andersen C; Ditzel HJ; Leth-Larsen R
    Int J Cancer; 2015 Nov; 137(9):2093-103. PubMed ID: 25912829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2 is a highly significant prognostic marker of hormone-receptor-positive, human epidermal growth factor receptor-2-negative breast cancer.
    Seong MK; Lee JY; Byeon J; Sohn YJ; Seol H; Lee JK; Kim EK; Kim HA; Noh WC
    Breast Cancer Res Treat; 2015 Feb; 150(1):141-8. PubMed ID: 25682076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of S100A16 subcellular localization in lung adenocarcinoma.
    Kobayashi M; Nagashio R; Saito K; Aguilar-Bonavides C; Ryuge S; Katono K; Igawa S; Tsuchiya B; Jiang SX; Ichinoe M; Murakumo Y; Saegusa M; Satoh Y; Sato Y
    Hum Pathol; 2018 Apr; 74():148-155. PubMed ID: 29320753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
    Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
    BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.
    Sakurai M; Miki Y; Takagi K; Suzuki T; Ishida T; Ohuchi N; Sasano H
    Breast Cancer Res; 2017 Jun; 19(1):70. PubMed ID: 28629450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100A14 regulates the invasive potential of oral squamous cell carcinoma derived cell-lines in vitro by modulating expression of matrix metalloproteinases, MMP1 and MMP9.
    Sapkota D; Bruland O; Costea DE; Haugen H; Vasstrand EN; Ibrahim SO
    Eur J Cancer; 2011 Mar; 47(4):600-10. PubMed ID: 21074410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A16 is a Prognostic Marker for Lung Adenocarcinomas.
    Saito K; Kobayashi M; Nagashio R; Ryuge S; Katono K; Nakashima H; Tsuchiya B; Jiang SX; Saegusa M; Satoh Y; Masuda N; Sato Y
    Asian Pac J Cancer Prev; 2015; 16(16):7039-44. PubMed ID: 26514487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAMTS19 Suppresses Cell Migration and Invasion by Targeting S100A16 via the NF-κB Pathway in Human Gastric Cancer.
    Jiang Y; Yu X; Zhao Y; Huang J; Li T; Chen H; Zhou J; Huang Z; Yang Z
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33921267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival.
    Pelkonen M; Luostari K; Tengström M; Ahonen H; Berdel B; Kataja V; Soini Y; Kosma VM; Mannermaa A
    BMC Cancer; 2015 May; 15():431. PubMed ID: 26014348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A16 is a prognostic marker for colorectal cancer.
    Sun X; Wang T; Zhang C; Ning K; Guan ZR; Chen SX; Hong TT; Hua D
    J Surg Oncol; 2018 Feb; 117(2):275-283. PubMed ID: 28876468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RECK is not an independent prognostic marker for breast cancer.
    Gomes LR; Fujita A; Mott JD; Soares FA; Labriola L; Sogayar MC
    BMC Cancer; 2015 Oct; 15():660. PubMed ID: 26449734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.